1. Strong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function.
- Author
-
Kosamo S, Hisert KB, Dmyterko V, Nguyen C, Black RA, Holden TD, Radella F, Cotten PA, Goss CH, Aitken ML, and Wurfel MM
- Subjects
- Adult, Armadillo Domain Proteins metabolism, Correlation of Data, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Cytoskeletal Proteins metabolism, Down-Regulation, Female, Humans, Intracellular Signaling Peptides and Proteins metabolism, Male, Proto-Oncogene Proteins c-akt metabolism, United States epidemiology, Cystic Fibrosis diagnosis, Cystic Fibrosis epidemiology, Cystic Fibrosis immunology, Cystic Fibrosis physiopathology, Gene Expression Profiling methods, Immunity, Innate immunology, Respiratory Function Tests methods, Toll-Like Receptors agonists, Toll-Like Receptors immunology
- Abstract
Background: Cystic fibrosis (CF) airways disease varies widely among patients with identical cystic fibrosis transmembrane conductance regulator (CFTR) genotypes. Robust airway inflammation is thought to be deleterious in CF; inter-individual variation in Toll-like receptor (TLR)-mediated innate immune inflammatory responses (TMIIR) might account for a portion of the phenotypic variation. We tested if TMIIR in people with CF are different than those of healthy controls, and whether higher TMIIR in people with CF are associated with reduced lung function., Methods: We cultured whole blood from clinically stable subjects with CF (n = 76) and healthy controls (n = 45) with TLR agonists, and measured cytokine production and expression of TLR-associated genes. We tested for differences in TLR-stimulated cytokine levels between subjects with CF and healthy subjects, and for associations between cytokine and gene expression levels with baseline lung function (forced expiratory volume in one second percent predicted (FEV
1 %)) and decline in FEV1 % over time., Results: TMIIR in blood from subjects with CF were lower than in healthy controls. Expression of TLR regulators SARM1, TOLLIP, and AKT1 were downregulated in CF. In subjects with CF we found that lower TLR4-agonist-induced IL-8 was associated with lower FEV1 % at enrollment (p<0.001) and with greater five year FEV1 % decline (p<0.001)., Conclusions: TMIIR were lower in people with CF relative to healthy controls; however, unexpectedly, greater whole blood TMIIR were positively associated with lung function in people with CF. These findings suggest a complex interaction between inflammation and disease in people with CF., Competing Interests: Declaration of Competing Interest The authors report no conflicts of interest., (Copyright © 2019. Published by Elsevier B.V.)- Published
- 2020
- Full Text
- View/download PDF